US.ZBH · Zimmer Biomet

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.0262947296215845,
        "turnoverUsdM": 200.201336,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.ZBH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 82.1758,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.1,
      "take_profit_price": 91.8435,
      "target_multiplier": 1.6,
      "technical_strength": 1.43,
      "take_profit_percent": 5
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.052589459243169,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 51.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 88.2885,
    "ma50": 86.0146,
    "close": 87.47,
    "prevClose": 84.17,
    "avgVolume20": 2305190,
    "volumeRatio": 0.99,
    "changePercent": 3.92
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": -0.03836851363236582,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 1.000275329193198,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 1.4526676077187977,
      "volat_points": 2,
      "day_range_pct": 0.03818452040699672,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 51.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 7.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 38,
        "contribution": 7.6
      },
      {
        "raw": 8.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 57.33,
        "contribution": 8.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 63,
        "contribution": 6.3
      },
      {
        "raw": 15.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 50.33,
        "contribution": 15.1
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46.1,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 7.6/20分",
      "市場環境分析總分: 8.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.3/10分",
      "技術信號分析總分: 15.1/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 7.6,
      "市場環境": 8.6,
      "情緒分析": 4,
      "技術信號": 15.1,
      "風險管理": 6.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 200.201336,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.ZBH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.59
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 721.1040046000002,
                "ma50": 709.14960084,
                "name": "QQQ",
                "close": 712.59998,
                "points": 1.4
              },
              "spy": {
                "ma20": 741.0760042499999,
                "ma50": 737.4256017000001,
                "name": "SPY",
                "close": 744.78003,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.0262947296215845,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 1
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140787741,
                "url": "https://finnhub.io/api/news?id=9afe5ce9ad09b8a38dce53a9e01651e47af32c25ae0b50e55b2d777b83e018b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement includes a collaboration between the companies to advance the iovera spasticity program. The transaction is expected to close in the third quarter of 2026, subject to customary conditions. Zimmer Biomet operates as a large medical device company with a core focus on orthopedics and related surgical solutions. The planned addition of the iovera device extends its reach...",
                "category": "company",
                "datetime": 1782966583,
                "headline": "Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity"
              },
              {
                "id": 140715814,
                "url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
                "category": "company",
                "datetime": 1782314640,
                "headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
              },
              {
                "id": 140602225,
                "url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
                "category": "company",
                "datetime": 1781137165,
                "headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
              },
              {
                "id": 140581614,
                "url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
                "category": "company",
                "datetime": 1781015440,
                "headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
              },
              {
                "id": 140573692,
                "url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
                "category": "company",
                "datetime": 1780938510,
                "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              }
            ],
            "raw_source": [
              {
                "id": 140793255,
                "url": "https://finnhub.io/api/news?id=879a4e66ccf970cbf4582895e4d1e997846752bfe4031a28dcf728039c875eb9",
                "image": "",
                "source": "Benzinga",
                "related": "ZBH",
                "summary": "https://www.reuters.com/legal/litigation/medical-device-maker-zimmer-biomet-hire-500-3-years-tech-centre-india-2026-07-02/",
                "category": "company",
                "datetime": 1782978264,
                "headline": "Reported Earlier: 'Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India' - Reuters"
              },
              {
                "id": 140787741,
                "url": "https://finnhub.io/api/news?id=9afe5ce9ad09b8a38dce53a9e01651e47af32c25ae0b50e55b2d777b83e018b3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings (NYSE:ZBH) agreed to acquire Pacira BioSciences’ FDA cleared iovera pain relief device. The agreement includes a collaboration between the companies to advance the iovera spasticity program. The transaction is expected to close in the third quarter of 2026, subject to customary conditions. Zimmer Biomet operates as a large medical device company with a core focus on orthopedics and related surgical solutions. The planned addition of the iovera device extends its reach...",
                "category": "company",
                "datetime": 1782966583,
                "headline": "Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity"
              },
              {
                "id": 140780933,
                "url": "https://finnhub.io/api/news?id=b4ac3a37e261572e3a1cd3747e2aa4f51540e6fe35526e061e3caf43da72df81",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth.",
                "category": "company",
                "datetime": 1782912600,
                "headline": "Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal"
              },
              {
                "id": 140778930,
                "url": "https://finnhub.io/api/news?id=8fa4c9db1d584311bb3c5437b6158651c630d41b8757811612476a781c4b411f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "The milestone payments may be achieved up to and through 31 December 2031.",
                "category": "company",
                "datetime": 1782903222,
                "headline": "Zimmer Biomet to acquire iovera device from Pacira for $140m"
              },
              {
                "id": 140774512,
                "url": "https://finnhub.io/api/news?id=60d4e872b38b8a51020c9e003ba137fc0486811d85f7026d6e974ba19d46aa88",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.9%",
                "category": "company",
                "datetime": 1782848500,
                "headline": "Sector Update: Healthcare Stocks Softer Late Afternoon"
              },
              {
                "id": 140774276,
                "url": "https://finnhub.io/api/news?id=1607dff3285f4bc45cf8ebe7c9ed22e9600f5e1d933634515c11aa2327149b00",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ZBH",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1782846300,
                "headline": "Top S&P500 movers in Tuesday's session"
              },
              {
                "id": 140774481,
                "url": "https://finnhub.io/api/news?id=270953dbf29511aad9077eed7db822da25e444433486ffb4fb72941ef5507c77",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Unicycive Therapeutics (UNCY) said Tuesday it has received a Complete Response Letter from the US Fo",
                "category": "company",
                "datetime": 1782844915,
                "headline": "Top Midday Decliners"
              },
              {
                "id": 140774488,
                "url": "https://finnhub.io/api/news?id=261338b9b78ed5915f2fee752834c40359424aaa563a9a0a792e5a54710fd5d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "(Updates with latest market prices and developments.) US benchmark equity indexes were higher int",
                "category": "company",
                "datetime": 1782843046,
                "headline": "Update: Equity Markets Rise Intraday, Poised for Strong Quarterly Gains"
              },
              {
                "id": 140773477,
                "url": "https://finnhub.io/api/news?id=3e5dbaa5f8c8004c8960d729c7cba34588960cbb748b5ab7110164b56be8baa5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "(Updates with index/price moves, macroeconomic data, and company news from the first paragraph.)",
                "category": "company",
                "datetime": 1782841339,
                "headline": "Update: US Equity Indexes Rise as Semiconductors Lift Technology; Crude Oil Slips as Trump's Envoys in Qatar for Indirect Talks"
              },
              {
                "id": 140773254,
                "url": "https://finnhub.io/api/news?id=45ffab8e93f60bba9fc6207e83277e70f09ef21e40612c43f8cf49acb4ed4d4b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "ZBH",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1782837301,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 140772425,
                "url": "https://finnhub.io/api/news?id=416f249f755256b353a3fd34343f96d0e73574196c62702bd4fc1f575a4f171c",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "ZBH",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1782830101,
                "headline": "These S&P500 stocks are gapping in today's session"
              },
              {
                "id": 140773686,
                "url": "https://finnhub.io/api/news?id=a8f83b0bc9896af23e1f8da30f2a6d659220a17695682c12a72d0b5b8d649737",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Rally-tops-amid-skepticism.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "ZBH",
                "summary": "Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end",
                "category": "company",
                "datetime": 1782825966,
                "headline": "AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today"
              },
              {
                "id": 140781677,
                "url": "https://finnhub.io/api/news?id=ab65f7a3201d95ef11cd96835570ff682d86a3d9510e670ecc990714c0d3509f",
                "image": "https://image.cnbcfm.com/api/v1/image/108264191-1770764453454-gettyimages-2259521349-img_7851.jpeg?v=1770764487&w=1920&h=1080",
                "source": "CNBC",
                "related": "ZBH",
                "summary": "Here are the companies making headlines in midday trading.",
                "category": "company",
                "datetime": 1782825385,
                "headline": "Stocks making the biggest moves midday: AeroVironment, Abivax, Astera Labs, Watts Water Technologies & more"
              },
              {
                "id": 140771675,
                "url": "https://finnhub.io/api/news?id=984d611312aa412d9c70fcd4e56cf68ca2c996676796936f24c894bba16efdc6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "-- Pacira to receive up to $140 million with $70 million upfront and up to an additional $70 million in potential future revenue-based milestone payments -- -- Two companies will collaborate on advancing the spasticity program -- -- Supports 5x30 strategy and advances Pacira’s transition into an innovative biopharmaceutical company -- BRISBANE, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioi",
                "category": "company",
                "datetime": 1782819000,
                "headline": "Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet"
              },
              {
                "id": 140773047,
                "url": "https://finnhub.io/api/news?id=81fab510281b19bf92d1047d5001c9feda3ebcd2b30a291ab1fa1600602d0900",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Pacira’s iovera device uses cold therapy for targeted pain relief. An analyst said the addition complements Zimmer Biomet’s portfolio.",
                "category": "company",
                "datetime": 1782818249,
                "headline": "Zimmer to buy Pacira pain relief device for up to $140M"
              },
              {
                "id": 140773703,
                "url": "https://finnhub.io/api/news?id=c015c2c7944525bcc571d4ec7710403f44d4f20d64bf4e91e7692b43c8259308",
                "image": "",
                "source": "Benzinga",
                "related": "ZBH",
                "summary": "Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced the divestiture of iovera ®° to Zimmer",
                "category": "company",
                "datetime": 1782804994,
                "headline": "Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140M"
              },
              {
                "id": 140762790,
                "url": "https://finnhub.io/api/news?id=60b52af90ae1b9982c81cb5eeee5b465c4ea6069fc78b747a36b1688e85074f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "CAMBRIDGE, Mass., June 29, 2026--Today, Pixee Medical announced the appointment of American healthcare executive Kristoff Goson as new Chief Executive Officer. A former senior executive at Zimmer Biomet, Goson will lead the company’s U.S. commercial expansion and global growth strategy as demand increases for more accessible and simplified surgical guidance technologies.",
                "category": "company",
                "datetime": 1782745200,
                "headline": "Pixee Medical Names Kristoff Goson CEO, Signaling Major Push for U.S. Market Growth"
              },
              {
                "id": 140715814,
                "url": "https://finnhub.io/api/news?id=36eb28a8270750c86ed8bc23e2ca5708f0ab83df06a973b054459d97cfe0c8fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.",
                "category": "company",
                "datetime": 1782314640,
                "headline": "ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?"
              },
              {
                "id": 140705492,
                "url": "https://finnhub.io/api/news?id=1374c0428d1b2f30e94c855825a137bd852b3b4e88be883228e4e073a0ee8595",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.",
                "category": "company",
                "datetime": 1782238309,
                "headline": "The Cash-Flow Fortress The Stryker Stock Bears Keep Missing"
              },
              {
                "id": 140674630,
                "url": "https://finnhub.io/api/news?id=c887ce6e4e116e43389a0f14f6ba20c49b9d6c34f3aa63a2e9c3fe00aacf834a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Insulet Corporation has underperformed the healthcare sector over the past year. However, analysts remain strongly bullish about its prospects.",
                "category": "company",
                "datetime": 1781885326,
                "headline": "Insulet Corporation Stock: Is PODD Underperforming the Healthcare Sector?"
              },
              {
                "id": 140671540,
                "url": "https://finnhub.io/api/news?id=b85f73c9839ef1c88922e1e344a59e1c8b958316f1c6760961e5524a9583e6e1",
                "image": "https://image.cnbcfm.com/api/v1/image/108323633-5ED3-MM-E-BLOCK-061726.jpg?v=1781738910&w=1920&h=1080",
                "source": "CNBC",
                "related": "ZBH",
                "summary": "'Mad Money' host Jim Cramer weighs in on stocks including: Fair Isaac Corporation, Clover Health, Vistra, and Stryker Corporation.",
                "category": "company",
                "datetime": 1781726833,
                "headline": "Lightning Round: I like FICO but I am afraid it's going to be hurt by AI, says Jim Cramer"
              },
              {
                "id": 140643627,
                "url": "https://finnhub.io/api/news?id=1cf6cf264296e34cf6aa6b883260c6b94b4448c6df4d5586d01127206df8dadb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210914563/image_2210914563.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet (ZBH) looks undervalued: strong free cash flow, high margins, sales/EPS growth, buybacks and manageable debt. See more details here.",
                "category": "company",
                "datetime": 1781581929,
                "headline": "Zimmer Biomet: Does Slow And Steady Still Win The Race?"
              },
              {
                "id": 140638992,
                "url": "https://finnhub.io/api/news?id=55c6e6735b3614e92e560eaa15ab79337321693464dc85a5555a3aab2a2c0302",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook.",
                "category": "company",
                "datetime": 1781524151,
                "headline": "Is Zimmer Biomet Stock Underperforming the S&P 500?"
              },
              {
                "id": 140613133,
                "url": "https://finnhub.io/api/news?id=fa7dc8445299911bf16502caaeab45d89c5c4cbbc69b958e2ee1a72a63a007d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is SOLV a good stock to buy? We came across a bullish thesis on Solventum Corporation on r/ValueInvesting by raytoei. In this article, we will summarize the bulls’ thesis on SOLV. Solventum Corporation’s share was trading at $82.46 as of June 9th. SOLV’s trailing and forward P/E were 10.09 and 12.58 respectively according to Yahoo Finance. Solventum […]",
                "category": "company",
                "datetime": 1781208796,
                "headline": "Is Solventum Corporation (SOLV) A Good Stock To Buy Now?"
              },
              {
                "id": 140602225,
                "url": "https://finnhub.io/api/news?id=9fe49e482bc56bb05f6d592cd872efd951762204c6033e9b9fab15984cbee012",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings currently sits with no changes to its published price targets, so you are working with the same reference points that were already in place. With no fresh analyst commentary on record, recent market moves are not being framed by new Wall Street narratives. Read on to see how you can track future revisions and keep up with how the story around this stock evolves over time. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to...",
                "category": "company",
                "datetime": 1781137165,
                "headline": "Why The Narrative Around Zimmer Biomet (ZBH) Is Shifting Without New Analyst Updates"
              },
              {
                "id": 140581614,
                "url": "https://finnhub.io/api/news?id=e807ea147c809c9a05caecce5563b33b2635da17565f7f169c1e40b8dcce745a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Is ZBH a good stock to buy? We came across a bullish thesis on Zimmer Biomet Holdings, Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on ZBH. Zimmer Biomet Holdings, Inc.’s share was trading at $87.27 as of June 8th. ZBH’s trailing and forward P/E were 22.62 and 10.46 respectively according […]",
                "category": "company",
                "datetime": 1781015440,
                "headline": "Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?"
              },
              {
                "id": 140581511,
                "url": "https://finnhub.io/api/news?id=46db3f2ddb8f68a9fda811f499351527e0ebbe2252337876f92aa9582fde5c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.",
                "category": "company",
                "datetime": 1781014020,
                "headline": "Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?"
              },
              {
                "id": 140581528,
                "url": "https://finnhub.io/api/news?id=fff801fa2f8f5420353b512baf5d61c8d4ac7e0cb77437df58f4af361c100815",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "ZBH",
                "summary": "Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.",
                "category": "company",
                "datetime": 1781013660,
                "headline": "Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom"
              },
              {
                "id": 140573692,
                "url": "https://finnhub.io/api/news?id=3c731df515e487f63c0aeca355fc5c45231f7a5fdfaa49df13f31c359af95d84",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "ZBH",
                "summary": "Zimmer Biomet Holdings, Inc. (ZBH) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:40 AM EDTCompany ParticipantsIvan Tornos -...",
                "category": "company",
                "datetime": 1780938510,
                "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1,
            "source_article_count": 29,
            "discarded_article_count": 24
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 15.1,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 0.4,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.4,
            "vcp_reason": "站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2317700,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2634450,
              "avg_vol_20": 2288170,
              "avg_vol_30": 2317700,
              "range_pct_10": 0.10998056476506236,
              "range_pct_20": 0.11238138790442435,
              "range_pct_30": 0.1344460958042758,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.136665659921474,
              "dist_to_20d_high": 0.06288836511677742,
              "down_shrink_days": 1,
              "breakout_level_20d": 93.34,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.8180272108843538
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.0262947296215845,
              "turnoverUsdM": 200.201336,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.ZBH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 82.1758,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.1,
            "take_profit_price": 91.8435,
            "target_multiplier": 1.6,
            "technical_strength": 1.43,
            "take_profit_percent": 5
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.052589459243169,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 2.6471,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.03
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -91.27
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.148
    },
    "kdj": {
      "d": 49.78,
      "j": 18.07,
      "k": 39.21,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 60.31
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 2113700,
      "recentSlope": -195590,
      "previousSlope": 349390
    },
    "rsi": 50.66,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 92.959,
      "position": "SAR喺價上",
      "distancePct": 6.28,
      "previousTrend": "下降"
    },
    "ma50": 86.0146,
    "macd": {
      "macd": 0.4587139989472746,
      "trend": "中性偏多",
      "signal": 0.7564325148534528,
      "histogram": -0.29771851590617815
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 88.1797,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.99,
      "score": 4,
      "avgVolume": 2305190,
      "currentVolume": 2288800
    },
    "derived": {
      "ma20": 88.2885,
      "ma50": 86.0146,
      "prevClose": 84.17,
      "avgVolume10": 2678710,
      "avgVolume20": 2305190,
      "changePercent": 3.92,
      "avgVolumeForScore": 2305190
    },
    "ma_cross": {
      "ma20": 88.2885,
      "ma50": 86.0146,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 88.164,
      "prevMa50": 86.119,
      "spreadPct": 2.64,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 84.3196,
      "upper": 92.2574,
      "position": "中間"
    },
    "rsi_short": 39.54,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.99
    }
  }
}

{
  "close": 87.47,
  "volume": 2288800,
  "changePercent": 3.92
}